We are live on ! Find out more
PODD icon

Insulet

813 hedge funds and large institutions have $21.1B invested in Insulet in 2025 Q3 according to their latest regulatory filings, with 108 funds opening new positions, 339 increasing their positions, 244 reducing their positions, and 82 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more repeat investments, than reductions

Existing positions increased: 339 | Existing positions reduced: 244

32% more first-time investments, than exits

New positions opened: 108 | Existing positions closed: 82

2% more funds holding

Funds holding: 796813 (+17)

4% less capital invested

Capital invested by funds: $22B → $21.1B (-$935M)

2.6% less ownership

Funds ownership: 99.62%97.02% (-2.6%)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

48% less call options, than puts

Call options by funds: $98.5M | Put options by funds: $191M

Holders
813
Holders Change
+17
Holders Change %
+2.14%
% of All Funds
10.64%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
108
Increased
339
Reduced
244
Closed
82
Calls
$98.5M
Puts
$191M
Net Calls
-$92.2M
Net Calls Change
+$24.3M

PODD Hedge Fund Activity: Q3 2025 in Review

813 of the 7,639 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q3 2025, worth a combined $21.1B — down 4.2% from $22B a quarter earlier.

Buyers outnumbered sellers: 108 funds opened new PODD positions and 82 closed out — a net gain of 26 holders — while 339 added to existing stakes and 244 trimmed.

The largest buyer was Squarepoint, adding an estimated $70.6M. The largest seller was Citadel Advisors, cutting an estimated $131M.

  • 813 institutional investors held Insulet (PODD) as of Q3 2025, up from 796 in Q2 2025.
  • Funds reported $21.1B of Insulet stock for Q3 2025, down 4.2% quarter-over-quarter.
  • 108 funds opened new Insulet positions in Q3 2025 and 82 closed out, a net change of +26 holders.
  • The largest Insulet buyer in Q3 2025 was Squarepoint, an estimated $70.6M added.
  • The largest Insulet seller in Q3 2025 was Citadel Advisors, an estimated $131M sold.

Based on aggregated 13F filings for Q3 2025.